A novel mechanism of immunosuppression in sepsis: Depletion of monocytes and macrophages
脓毒症免疫抑制的新机制:单核细胞和巨噬细胞的耗竭
基本信息
- 批准号:10020416
- 负责人:
- 金额:$ 37.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-20 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectApoptosisB-LymphocytesBacteriaBindingCASP1 geneCaspaseCell DeathCell membraneCellsCessation of lifeCleaved cellClinical ResearchDataDendritic CellsDiseaseDisseminated Intravascular CoagulationEffector CellEscherichia coliFamily memberFlagellinGoalsGram-Negative BacteriaGram-Negative Bacterial InfectionsImmuneImmune responseImmunosuppressionImpairmentIn VitroInfectionInflammasomeInflammatoryLeadLifeModelingMolecularMorbidity - disease rateMusN-terminalPathogenesisPathway interactionsPatientsPeripheralPhagocytosisPlayProteinsReportingResearch Project GrantsRodRoleRuptureSepsisT-Cell DepletionTestingThromboplastinTissuesType III Secretion System PathwayUnited StatesWorkacyl-CoA dehydrogenasececal ligation puncturedriving forceinsightintravenous injectionmacrophagemonocytemortalitymouse modelnew therapeutic targetnovelpathogenrelease factorresponseseptic patients
项目摘要
Sepsis is a life-threatening condition that affects more than 1 million patients a year in the United States.
Growing evidence indicates that immunosuppression is a major driving force for mortality in sepsis.
Macrophages play essential roles in immune response to pathogens. Previous clinical studies have shown that
peripheral monocytes are depleted in septic patients through apoptosis. Recent in vitro studies revealed that
bacterial components, flagellin, the rod protein of the type III secretion system (T3SS), or LPS induce
pyroptosis of macrophages through activation of inflammasome pathways. In this proposal, we provide
convincing evidence that both peripheral monocytes and tissue macrophages are depleted due to pyroptosis in
mouse sepsis models including the cecal ligation and puncture (CLP) model. We show that intravenous
injection of flagellin or the rod proteins induced depletion of peripheral monocytes and macrophages in tissues.
We further demonstrate that depletion of these cells in mice impaired immune response and increased
mortality rate by subsequent challenged with E. coli. Importantly, our data indicate that tissue factor released
from pyroptotic monocytes and macrophages triggers disseminated intravascular coagulation (DIC). Thus, our
findings identified monocyte/macrophage depletion as a novel mechanism of immunosuppression and DIC in
sepsis. The goal of this application is to delineate the underlying mechanisms of monocyte/macrophage
depletion and its contribution to immunosuppression in sepsis. Aim 1 is to delineate the mechanisms of
pyroptotic monocyte and macrophage death during sepsis. The working hypothesis is that inflammasome
activation and subsequent pyroptosis play a critical role in monocyte/macrophage depletion during sepsis.
Mouse models deficient in caspase-1, caspase-11, caspase-1/11 double, or GSDMD (whole-body and
macrophage-specific) will be used to elucidate the detailed mechanism of inflammasome activation and
pyroptosis in monocyte/macrophage depletion. Aim 2 is to identify the mechanism by which rod protein and
flagellin induce pyroptosis leading to monocyte/macrophage depletion. We recently identified an intracellular
binding partner of EprJ, the acyl-CoA dehydrogenase family member type 9 (ACAD9) in macrophages. We will
use different approaches to test the hypothesis that the ACAD9-dependent pathway contributes to
macrophage depletion. Aim 3 is to identify the contribution of monocyte/macrophage depletion to
immunosuppression during sepsis. We will use a combination of sepsis models to investigate the role of
monocyte/macrophage depletion in immunosuppression during sepsis. Peripheral monocyte depletion in septic
patients will also be investigated. Completion of the proposed studies will reveal a novel molecular mechanism
of immunosuppression induced by Gram-negative bacteria. Such findings will significantly advance our
understanding about the pathogenesis of sepsis and identify new drug targets for this deadly disease.
败血症是一种危及生命的疾病,在美国每年有超过100万患者受到影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZHENYU Li其他文献
ZHENYU Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZHENYU Li', 18)}}的其他基金
Inflammasome Activation Triggers Systemic Coagulation in Sepsis
脓毒症中炎症小体激活引发全身凝血
- 批准号:
10645452 - 财政年份:2022
- 资助金额:
$ 37.73万 - 项目类别:
A novel mechanism of immunosuppression in sepsis: Depletion of monocytes and macrophages
脓毒症免疫抑制的新机制:单核细胞和巨噬细胞的耗竭
- 批准号:
10436162 - 财政年份:2019
- 资助金额:
$ 37.73万 - 项目类别:
A novel mechanism of immunosuppression in sepsis: Depletion of monocytes and macrophages
脓毒症免疫抑制的新机制:单核细胞和巨噬细胞的耗竭
- 批准号:
10194546 - 财政年份:2019
- 资助金额:
$ 37.73万 - 项目类别:
A novel mechanism of immunosuppression in sepsis: Depletion of monocytes and macrophages
脓毒症免疫抑制的新机制:单核细胞和巨噬细胞的耗竭
- 批准号:
10605060 - 财政年份:2019
- 资助金额:
$ 37.73万 - 项目类别:
Crosstalk between membrane traffic proteins and integrin activation
膜运输蛋白和整合素激活之间的串扰
- 批准号:
8837170 - 财政年份:2014
- 资助金额:
$ 37.73万 - 项目类别:
PLATELET ACTIVATION WITH OBESITY PROMOTES ATHEROTHROMBOTIC VASCULAR EVENTS
肥胖引起的血小板激活促进动脉粥样硬化性血管事件
- 批准号:
8360249 - 财政年份:2011
- 资助金额:
$ 37.73万 - 项目类别:
PLATELET ACTIVATION WITH OBESITY PROMOTES ATHEROTHROMBOTIC VASCULAR EVENTS
肥胖引起的血小板激活促进动脉粥样硬化性血管事件
- 批准号:
8174559 - 财政年份:2010
- 资助金额:
$ 37.73万 - 项目类别:
PLATELET ACTIVATION WITH OBESITY PROMOTES ATHEROTHROMBOTIC VASCULAR EVENTS
肥胖引起的血小板激活促进动脉粥样硬化性血管事件
- 批准号:
7960386 - 财政年份:2009
- 资助金额:
$ 37.73万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Regulation of Autophagy and Apoptosis in B lymphocytes
B 淋巴细胞自噬和凋亡的调节
- 批准号:
234605336 - 财政年份:2013
- 资助金额:
$ 37.73万 - 项目类别:
Research Grants
Regulation of apoptosis in B lymphocytes
B 淋巴细胞凋亡的调节
- 批准号:
155495-1997 - 财政年份:2000
- 资助金额:
$ 37.73万 - 项目类别:
Discovery Grants Program - Individual
Regulation of apoptosis in B lymphocytes
B 淋巴细胞凋亡的调节
- 批准号:
155495-1997 - 财政年份:1999
- 资助金额:
$ 37.73万 - 项目类别:
Discovery Grants Program - Individual
TGF BETA--INDUCED APOPTOSIS IN B LYMPHOCYTES
TGF Beta--诱导 B 淋巴细胞凋亡
- 批准号:
6124670 - 财政年份:1998
- 资助金额:
$ 37.73万 - 项目类别:
TGF BETA--INDUCED APOPTOSIS IN B LYMPHOCYTES
TGF Beta--诱导 B 淋巴细胞凋亡
- 批准号:
2743621 - 财政年份:1998
- 资助金额:
$ 37.73万 - 项目类别:














{{item.name}}会员




